Literature DB >> 27902858

Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.

Mikkel Bo Hansen1, Anna Tietze1,2,3, Jayashree Kalpathy-Cramer4, Elizabeth R Gerstner5, Tracy T Batchelor5, Leif Østergaard1,2, Kim Mouridsen1.   

Abstract

PURPOSE: To present and quantify the performance of a method to compute tissue hemodynamic parameters from dynamic susceptibility contrast (DSC) MRI data in brain tissue with possible nonintact blood-brain barrier. THEORY AND
MATERIALS AND METHODS: We propose a Bayesian scheme to obtain perfusion metrics, including capillary transit-time heterogeneity (CTH), from DSC-MRI data in the presence of contrast agent extravasation. Initial performance assessment is performed through simulations. Next, we assessed possible over- or under correction for tracer extravasation in two patients receiving contrast agent preloading and two patients not receiving preloading. Perfusion metrics for N = 60 patients diagnosed with either grade III (N = 14) or grade IV gliomas (N = 46) were analyzed across tissue types to evaluate the ability to distinguish regions with different hemodynamic patterns. Finally, N = 4 patient cases undergoing anti-angiogenic treatment are evaluated qualitatively for treatment effects. All patient data were acquired at 3.0 Tesla.
RESULTS: The simulation studies showed good robustness against low signal-to-noise ratios, exemplified with Pearson correlations of R = 0.833 (mean transit time) and R = 0.738 (CTH) at signal-to-noise ratio = 20. Region-of-interest analysis of the N = 60 glioma patients showed that cerebral blood volume (CBV) significantly separated enhancing core from edema (grade IV: P < 10-8 , grade III: P < 0.05) and enhancing core from normal appearing ipsilateral white matter (NAWM) (grade IV: P < 10-8 , grade III: P < 0.05). The microvascular parameters were particularly good in separating edematous tissue from NAWM tissue in grade IV gliomas (P < 0.001). Finally, CTH separated grade III and grade IV core tissue (P < 0.05).
CONCLUSION: We have demonstrated robustness of the proposed Bayesian algorithm against experimental noise and demonstrated complementary value in microvascular parameters to the CBV parameter in separating tissue types in gliomas. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:537-549.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  Bayesian expectation-maximization; DSC-MRI; capillary transit-time heterogeneity (CTH); cerebral neoplasms; contrast agent leakage; oxygen extraction fraction (OEF)

Mesh:

Substances:

Year:  2016        PMID: 27902858     DOI: 10.1002/jmri.25549

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.

Authors:  Andreas Stadlbauer; Kim Mouridsen; Arnd Doerfler; Mikkel Bo Hansen; Stefan Oberndorfer; Max Zimmermann; Michael Buchfelder; Gertraud Heinz; Karl Roessler
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-24       Impact factor: 6.200

2.  Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with 15O-Gas PET and Singular Value Decomposition.

Authors:  S Hara; Y Tanaka; S Hayashi; M Inaji; T Maehara; M Hori; S Aoki; K Ishii; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-10       Impact factor: 3.825

3.  ABCD1 dysfunction alters white matter microvascular perfusion.

Authors:  Arne Lauer; Xiao Da; Mikkel Bo Hansen; Gregoire Boulouis; Yangming Ou; Xuezhu Cai; Afonso Liberato Celso Pedrotti; Jayashree Kalpathy-Cramer; Paul Caruso; Douglas L Hayden; Natalia Rost; Kim Mouridsen; Florian S Eichler; Bruce Rosen; Patricia L Musolino
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

4.  Robust estimation of hemo-dynamic parameters in traditional DCE-MRI models.

Authors:  Mikkel B Hansen; Anna Tietze; Søren Haack; Jesper Kallehauge; Irene K Mikkelsen; Leif Østergaard; Kim Mouridsen
Journal:  PLoS One       Date:  2019-01-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.